
<DOC>
<DOCNO>
WSJ900612-0040
</DOCNO>
<DOCID>
900612-0040.
</DOCID>
<HL>
   Business Brief -- Immunex Corp.:
   Investor Richard C. Hedreen
   Increases Holding to 7.91%
</HL>
<DATE>
06/12/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   IMNX
</CO>
<IN>
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)
</IN>
<LP>
   Richard C. Hedreen, president of R.C. Hedreen Co.,
Seattle, said he raised his stake in Immunex Corp. to the
equivalent of 7.91% of the common shares outstanding.
   In a filing with the Securities and Exchange Commission,
Mr. Hedreen said that as of June 6 he controlled 633,789
Immunex common shares, assuming the conversion of debentures
and the exercise of warrants. His Immunex holdings include
securities held by immediate family members, the filing said.
</LP>
<TEXT>
   Last December, Mr. Hedreen said he controlled the
equivalent of a 6.39% stake in Immunex.
   In the filing, Mr. Hedreen said he acquired his Immunex
holdings solely for investment purposes.
   Seattle-based Immunex, a biotechnology concern, declined
to comment.
</TEXT>
</DOC>